Vascular Guidewires Market by Application (Coronary Guidewires, Peripheral Guidewires, Urology Guidewires, and Neurovascular Guidewires), Coating Type (Coated, and Non-Coated), and End User (Hospitals and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2018–2025
- ALL3201202
- 227 Pages
- May 2019
- Healthcare
A guidewire is a long and flexible spring that assists the introduction and placement of implantable medical devices into a patient’s body. Vascular guidewires are used during various interventional cardiology procedures (including placement of angioplasty balloons, stents, inferior vena cava filters, and others) as they guide a surgeon for the correct placement of these devices.
There is an increase in the demand for vascular guidewires due to rise in the prevalence of cardiovascular disorders, increase in geriatric population, demand for minimally invasive procedures, and rapid technological advancements in guidewires drive the market growth. However, risks and complications associated with guidewires, and availability of effective conventional treatment options restrict the market growth. Conversely, increase in use of nitinol in vascular guidewires and growth opportunities in the emerging economies of the Asia-Pacific and LAMEA are expected to provide several opportunities for market growth during the forecast period.
The vascular guidewires market is segmented based on application, coating type, end user, and region. Based on product, the market is segmented into coronary guidewires and peripheral guidewires. Depending on coating type, the market is categorized into coated and non-coated. Coated segment is further bifurcated into hydrophilic coating and hydrophobic coating. Based on end user, the market is segmented into hospitals and ambulatory surgical centers. Based on region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global vascular guidewires market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
• By Application
o Coronary Guidewires
o Peripheral Guidewires
o Urology Guidewires
o Neurovascular Guidewires
• By Coating Type
o Coated
Hydrophilic Coating
Hydrophobic Coating
o Non-Coated
• By End User
o Hospitals
o Ambulatory Surgical Centers (ASCs)
• By Region
o North America
• U.S.
• Canada
• Mexico
o Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
o Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific
o LAMEA
• Brazil
• South Africa
• Saudi Arabia
• Rest of LAMEA
KEY MARKET PLAYERS
• Abbott Laboratories
• B. Braun Melsungen AG
• Becton, Dickinson and Company (C.R. Bard)
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Medical Inc.
• Olympus Corporation
• Terumo Corporation
The other players in the value chain include (profiles not included in the report):
• Stryker Corporation
• Teleflex Incorporated
• AngioDynamics
• Asahi Intecc USA, Inc.
• Bard Peripheral Vascular, Inc.
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings
2.1.1. Top impacting factors
2.1.2. Top investment pockets
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Vascular Guidewires Market
3.3.1. Moderate bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. High bargaining power of buyers
3.4. Pricing Analysis
3.4.1. Pricing Analysis, By Region, 2018 & 2025
3.5. Value Chain Analysis
3.6. Impact of government regulations on global vascular guidewires market
3.7. Industry Pain point analysis
3.8. Patent Analysis
3.8.1. Patent analysis, by year
3.8.2. By Region (2016-2018)
3.8.3. By Applicant
3.9. Case Studies
3.9.1. Case Study 01
3.10. Market dynamics
3.10.1. Drivers
3.10.1.1. Increase in incidence of cardiac disorders and growth in geriatric population
3.10.1.2. Rise in patient awareness
3.10.1.3. Presence of high unmet medical needs
3.10.2. Restraints
3.10.2.1. Risks and complications associated with guidewires
3.10.2.2. Preference for drugs over treatment devices
3.10.3. Opportunities
3.10.3.1. Use of nitinol in vascular guidewires
CHAPTER 4: VASCULAR GUIDEWIRES MARKET, BY APPLICATION
4.1. Overview
4.2. Market size and forecast
4.3. Coronary guidewires
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis by country
4.4. Peripheral guidewires
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis by country
4.5. Urological Guidewires
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis by country
4.6. Neurovascular Guidewires
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis by country
CHAPTER 5: VASCULAR GUIDEWIRES MARKET, BY COATING TYPE
5.1. Overview
5.2. Market size and forecast
5.3. Coated
5.3.1. Market size and forecast, by type
5.3.1.1. Hydrophilic coating
5.3.1.1.1. Market size and forecast
5.3.1.2. Hydrophobic coating
5.3.1.2.1. Market size and forecast
5.3.2. Market size and forecast, by region
5.3.3. Market analysis by country
5.4. Non-Coated
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
CHAPTER 6: VASCULAR GUIDEWIRES MARKET, BY END USER
6.1. Overview
6.2. Market size and forecast
6.3. Hospitals
6.3.1. Market size and forecast, by region
6.3.2. Market analysis by country
6.4. Ambulatory surgical centers (ASCs)
6.4.1. Market size and forecast, by region
6.4.2. Market analysis by country
CHAPTER 7: VASCULAR GUIDEWIRES MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America vascular guidewires market, by country
7.2.2.1. U.S. vascular guidewires market by application
7.2.2.2. U.S. vascular guidewires market by coating type
7.2.2.3. U.S. vascular guidewires market by end user
7.2.2.4. Canada vascular guidewires market by application
7.2.2.5. Canada vascular guidewires market by coating type
7.2.2.6. Canada vascular guidewires market by end user
7.2.2.7. Mexico vascular guidewires market by application
7.2.2.8. Mexico vascular guidewires market by coating type
7.2.2.9. Mexico vascular guidewires market by end user
7.2.3. North America vascular guidewires market, by application
7.2.4. North America vascular guidewires market, by coating type
7.2.5. North America vascular guidewires market, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Europe vascular guidewires market, by country
7.3.2.1. Germany vascular guidewires market by application
7.3.2.2. Germany vascular guidewires market by coating type
7.3.2.3. Germany vascular guidewires market by end user
7.3.2.4. France vascular guidewires market by application
7.3.2.5. France vascular guidewires market by coating type
7.3.2.6. France vascular guidewires market by end user
7.3.2.7. Spain vascular guidewires market by application
7.3.2.8. Spain vascular guidewires market by coating type
7.3.2.9. Spain vascular guidewires market by end user
7.3.2.10. Italy vascular guidewires market by application
7.3.2.11. Italy vascular guidewires market by coating type
7.3.2.12. Italy vascular guidewires market by end user
7.3.2.13. UK vascular guidewires market by application
7.3.2.14. UK vascular guidewires market by coating type
7.3.2.15. UK vascular guidewires market by end user
7.3.2.16. Rest of Europe vascular guidewires market by application
7.3.2.17. Rest of Europe vascular guidewires market by coating type
7.3.2.18. Rest of Europe vascular guidewires market by end user
7.3.3. Europe vascular guidewires market, by application
7.3.4. Europe vascular guidewires market, by coating type
7.3.5. Europe vascular guidewires market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific vascular guidewires market, by country
7.4.2.1. Australia vascular guidewires market by application
7.4.2.2. Australia vascular guidewires market by coating type
7.4.2.3. Australia vascular guidewires market by end user
7.4.2.4. Japan vascular guidewires market by application
7.4.2.5. Japan vascular guidewires market by coating type
7.4.2.6. Japan vascular guidewires market by end user
7.4.2.7. India vascular guidewires market by application
7.4.2.8. India vascular guidewires market by coating type
7.4.2.9. India vascular guidewires market by end user
7.4.2.10. China vascular guidewires market by application
7.4.2.11. China vascular guidewires market by coating type
7.4.2.12. China vascular guidewires market by end user
7.4.2.13. South Korea vascular guidewires market by application
7.4.2.14. South Korea vascular guidewires market by coating type
7.4.2.15. South Korea vascular guidewires market by end user
7.4.2.16. Rest of Asia-Pacific vascular guidewires market by application
7.4.2.17. Rest of Asia-Pacific vascular guidewires market by coating type
7.4.2.18. Rest of Asia-Pacific vascular guidewires market by end user
7.4.3. Asia-Pacific vascular guidewires market, by application
7.4.4. Asia-Pacific vascular guidewires market, by coating type
7.4.5. Asia-Pacific vascular guidewires market, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA vascular guidewires market, by country
7.5.2.1. Brazil vascular guidewires market by application
7.5.2.2. Brazil vascular guidewires market by coating type
7.5.2.3. Brazil vascular guidewires market by end user
7.5.2.4. Saudi Arabia vascular guidewires market by application
7.5.2.5. Saudi Arabia vascular guidewires market by coating type
7.5.2.6. Saudi Arabia vascular guidewires market by end user
7.5.2.7. South Africa vascular guidewires market by application
7.5.2.8. South Africa vascular guidewires market by coating type
7.5.2.9. South Africa vascular guidewires market by end user
7.5.2.10. Rest of LAMEA vascular guidewires market by application
7.5.2.11. Rest of LAMEA vascular guidewires market by coating type
7.5.2.12. Rest of LAMEA vascular guidewires market by end user
7.5.3. LAMEA vascular guidewires market, by application
7.5.4. LAMEA vascular guidewires market, by coating type
7.5.5. LAMEA vascular guidewires market, by end user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Market Share Analysis of Top Players, 2018 (%)
8.3. Product Mapping of Top 10 Player
CHAPTER 9: COMPANY PROFILES:
9.1. Abbott Laboratories
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.2. B. Braun Melsungen AG
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.3. Becton, Dickinson and Company (C.R. Bard)
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.4. Biotronik SE & Co. KG
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments
9.5. Boston Scientific Corporation
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. Cardinal Health, Inc.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. Cook Medical Inc.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.8. Medtronic Plc. (Covidien Ltd.)
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.9. Olympus Corporation
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.10. Terumo Corporation
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
TABLE 01. GLOBAL VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 02. VASCULAR GUIDEWIRES MARKET REVENUE FOR CORONARY GUIDEWIRES, BY REGION 2017–2025 ($MILLION)
TABLE 03. VASCULAR GUIDEWIRES MARKET REVENUE FOR PERIPHERAL GUIDEWIRES, BY REGION 2017–2025($MILLION)
TABLE 04. VASCULAR GUIDEWIRES MARKET REVENUE FOR UROLOGICAL GUIDEWIRES, BY REGION 2017–2025($MILLION)
TABLE 05. VASCULAR GUIDEWIRES MARKET REVENUE FOR NEUROVASCULAR GUIDEWIRES, BY REGION 2017–2025($MILLION)
TABLE 06. GLOBAL VASCULAR GUIDEWIRES MARKET REVENUE, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 07. COATED VASCULAR GUIDEWIRES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 08. VASCULAR GUIDEWIRES MARKET REVENUE FOR COATED VASCULAR GUIDEWIRES, BY REGION 2017–2025($MILLION)
TABLE 09. VASCULAR GUIDEWIRES MARKET REVENUE FOR NON-COATED VASCULAR GUIDEWIRES, BY REGION 2017–2025($MILLION)
TABLE 10. GLOBAL VASCULAR GUIDEWIRES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 11. VASCULAR GUIDEWIRES MARKET REVENUE FOR HARDWARE, BY REGION 2017–2025($MILLION)
TABLE 12. VASCULAR GUIDEWIRES MARKET REVENUE FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION 2017–2025($MILLION)
TABLE 13. GLOBAL VASCULAR GUIDEWIRES MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 14. GLOBAL VASCULAR GUIDEWIRES MARKET, BY REGION, 2017–2025 (THOUSAND UNITS)
TABLE 15. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 16. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY COUNTRY, 2017-2025 (THOUSAND UNITS)
TABLE 17. U.S. VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 18. U.S. VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 19. U.S. VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 20. CANADA VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 21. CANADA VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 22. CANADA VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 23. MEXICO VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 24. MEXICO VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 25. MEXICO VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 26. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 27. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 28. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 29. EUROPE VASCULAR GUIDEWIRES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 30. EUROPE VASCULAR GUIDEWIRES MARKET, BY COUNTRY, 2017-2025 (THOUSAND UNITS)
TABLE 31. GERMANY VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 32. GERMANY VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 33. GERMANY VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 34. FRANCE VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 35. FRANCE VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 36. FRANCE VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 37. SPAIN VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 38. SPAIN VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 39. SPAIN VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 40. ITALY VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 41. ITALY VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 42. ITALY VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 43. UK VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 44. UK VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 45. UK VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 46. REST OF EUROPE VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 47. REST OF EUROPE VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 48. REST OF EUROPE VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 49. EUROPE VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 50. EUROPE VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 51. EUROPE VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 52. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 53. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY COUNTRY, 2017-2025 (THOUSAND UNITS)
TABLE 54. AUSTRALIA VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 55. AUSTRALIA VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 56. AUSTRALIA VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 57. JAPAN VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 58. JAPAN VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 59. JAPAN VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 60. INDIA VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 61. INDIA VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 62. INDIA VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 63. CHINA VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 64. CHINA VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 65. CHINA VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 66. SOUTH KOREA VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 67. SOUTH KOREA VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 68. SOUTH KOREA VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 72. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 73. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 74. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 75. LAMEA VASCULAR GUIDEWIRES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 76. LAMEA VASCULAR GUIDEWIRES MARKET, BY COUNTRY, 2017-2025 (THOUSAND UNITS)
TABLE 77. BRAZIL VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 78. BRAZIL VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 79. BRAZIL VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 80. SAUDI ARABIA VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 81. SAUDI ARABIA VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 82. SAUDI ARABIA VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 83. SOUTH AFRICA VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 84. SOUTH AFRICA VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 85. SOUTH AFRICA VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 86. REST OF LAMEA VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 87. REST OF LAMEA VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 88. REST OF LAMEA VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 89. LAMEA VASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 90. LAMEA VASCULAR GUIDEWIRES MARKET, BY COATING TYPE, 2017-2025 ($MILLION)
TABLE 91. LAMEA VASCULAR GUIDEWIRES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 92. ABBOTT: COMPANY SNAPSHOT
TABLE 93. ABBOTT: OPERATING SEGMENTS
TABLE 94. ABBOTT: PRODUCT PORTFOLIO
TABLE 95. B. BRAUN: COMPANY SNAPSHOT
TABLE 96. B. BRAUN: OPERATING SEGMENTS
TABLE 97. B. BRAUN: PRODUCT PORTFOLIO
TABLE 98. BD: COMPANY SNAPSHOT
TABLE 99. BD: OPERATING SEGMENTS
TABLE 100. BD: PRODUCT PORTFOLIO
TABLE 101. BIOTRONIK: COMPANY SNAPSHOT
TABLE 102. BIOTRONIK: OPERATING SEGMENTS
TABLE 103. BIOTRONIK: PRODUCT PORTFOLIO
TABLE 104. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 105. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 106. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 107. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 108. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 109. CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 110. COOK MEDICAL: COMPANY SNAPSHOT
TABLE 111. COOK MEDICAL: OPERATING SEGMENTS
TABLE 112. COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 113. MEDTRONIC: COMPANY SNAPSHOT
TABLE 114. MEDTRONIC: OPERATING SEGMENTS
TABLE 115. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 116. OLYMPUS: COMPANY SNAPSHOT
TABLE 117. OLYMPUS: OPERATING SEGMENTS
TABLE 118. OLYMPUS: PRODUCT PORTFOLIO
TABLE 119. TERUMO: COMPANY SNAPSHOT
TABLE 120. TERUMO: OPERATING SEGMENTS
TABLE 121. TERUMO: PRODUCT PORTFOLIO
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
